Blockade of the co-inhibitory molecule PD-1 unleashes ILC2-dependent antitumor immunity in melanoma.
Nature Immunology
Accession number
34099918
Pages
851-+
Volume
22
URL
https://pubmed.ncbi.nlm.nih.gov/34099918/